Cutlass Capital, L.L.C.
Venture capitalBoston · Seed–Late Stage · 1 people tracked
Investment thesis
Cutlass Capital is a venture capital partnership that invests in healthcare companies. The firm operates as a private partnership.
Team · 1 people
from public directoriesFrequently asked questions
- What stage does Cutlass Capital, L.L.C. invest at?
- Cutlass Capital, L.L.C. invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What is Cutlass Capital, L.L.C.'s typical check size?
- Cutlass Capital, L.L.C. typically writes checks of $3M – $7M.
- What sectors does Cutlass Capital, L.L.C. focus on?
- Cutlass Capital, L.L.C. focuses on Healthtech, Medical Devices.
- Where is Cutlass Capital, L.L.C. located?
- Cutlass Capital, L.L.C. is headquartered in Boston, US.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Pappas Capital is a life sciences venture capital firm that invests in and helps build companies developing next-generation life science products and technologies.
Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.
Norrsken22 is a tech growth fund focused on Africa, providing growth capital and strategic support to entrepreneurs while positioning them for international expansion. It is backed by the Norrsken Foundation and a network of tech founders.
JSTAR Capital Investments is a healthcare-focused investment firm backing medical technology companies, providing capital and expert guidance to advance patient care and address global healthcare challenges.